why choose us

First received: November 22, 2022

Clinical Trial: Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Adverse Effect of Drugs and Medicaments in Therapeutic Use

Study Type: INTERVENTIONAL


Official Title: A Phase I, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers

Brief Summary: The goal of this clinical trial is to assess the safety, tolerability and pharmacokinetics of ATL-001 (ciclopirox olamine) in healthy volunteers

Read more